Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Cash Flow-to-Debt Ratio
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Cash Flow-to-Debt Ratio of -0.09x as of September 2025, meaning its operating cash flow of CN¥-243.75 Million could theoretically repay 0% of its total liabilities (CN¥2.68 Billion) in one year. See 600566 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2000–2024)
Historical debt coverage capacity for Hubei Jumpcan Pharmaceutical Co Ltd across 25 annual periods. Also explore net asset growth rate of Hubei Jumpcan Pharmaceutical Co Ltd to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2024)
Year-by-year debt coverage analysis for Hubei Jumpcan Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 600566 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.58x | CN¥2.18 Billion | CN¥3.73 Billion | ▼ -19.6% |
| 2023 | 0.73x | CN¥3.46 Billion | CN¥4.77 Billion | ▲ +0.4% |
| 2022 | 0.72x | CN¥2.62 Billion | CN¥3.63 Billion | ▲ +14.4% |
| 2021 | 0.63x | CN¥1.89 Billion | CN¥3.00 Billion | ▼ -2.4% |
| 2020 | 0.65x | CN¥1.78 Billion | CN¥2.75 Billion | ▼ -22.8% |
| 2019 | 0.84x | CN¥2.15 Billion | CN¥2.56 Billion | ▲ +14.8% |
| 2018 | 0.73x | CN¥1.71 Billion | CN¥2.34 Billion | ▲ +38.9% |
| 2017 | 0.53x | CN¥1.19 Billion | CN¥2.26 Billion | ▼ -25.1% |
| 2016 | 0.70x | CN¥913.10 Million | CN¥1.30 Billion | ▼ -5.1% |
| 2015 | 0.74x | CN¥645.48 Million | CN¥872.59 Million | ▲ +27.7% |
| 2014 | 0.58x | CN¥616.11 Million | CN¥1.06 Billion | ▲ +73.9% |
| 2013 | 0.33x | CN¥287.16 Million | CN¥862.04 Million | ▲ +519.2% |
| 2012 | 0.05x | CN¥27.01 Million | CN¥502.07 Million | ▲ +5590.6% |
| 2011 | 0.00x | CN¥411.24K | CN¥435.00 Million | ▼ -99.4% |
| 2010 | 0.15x | CN¥51.13 Million | CN¥342.89 Million | ▲ +880.6% |
| 2009 | 0.02x | CN¥4.92 Million | CN¥323.37 Million | ▼ -78.7% |
| 2008 | 0.07x | CN¥23.05 Million | CN¥323.43 Million | ▼ -41.1% |
| 2007 | 0.12x | CN¥36.72 Million | CN¥303.49 Million | ▲ +757.6% |
| 2006 | 0.01x | CN¥4.24 Million | CN¥300.69 Million | ▼ -94.4% |
| 2005 | 0.25x | CN¥63.38 Million | CN¥251.96 Million | ▲ +249.3% |
| 2004 | -0.17x | CN¥-37.74 Million | CN¥223.98 Million | ▼ -1481.1% |
| 2003 | 0.01x | CN¥2.24 Million | CN¥183.92 Million | ▼ -91.8% |
| 2002 | 0.15x | CN¥22.00 Million | CN¥148.17 Million | ▲ +166.1% |
| 2001 | 0.06x | CN¥7.43 Million | CN¥133.08 Million | ▼ -80.4% |
| 2000 | 0.28x | CN¥23.73 Million | CN¥83.37 Million | — |